Closed/Completed Trials

Sponsor Study

Enrollment Closed

pSivida A Phase III, Multi-National, Multi-Center, Randomized, Masked, Controlled, Safety and Efficacy Study of a Fluocinolone Acetonide Intravitreal (FAI) Insert in Subjects with Chronic Non-Infectious Uveitis Affecting the Posterior Segment of the Eye

Study Completed

Alcon
(C-12-074)
A Multi-center, Open label, Single Ascending Dose Study to Assess the Safety, Tolerability, and Serum Pharmacokinetics of Intravitreal CLG561 in Subjects with Advanced, Age-related Macular Degeneration
Alcon
(Osprey)
A Prospective, Randomized, Double-Masked, Multicenter, Two Arm Study, Comparing the Efficacy and Safety of ESBA1008 versus EYLEA® in Subjects with Exudative Age-Related Macular Degeneration
Alcon ESBA1008 Safety, Tolerability and Effects in Wet Age-related Macular Degeneration (AMD) Patients: The purpose of this study is to evaluate the safety, tolerability and effects of an investigational drug ESBA1008 for the treatment of exudative age-related macular degeneration
Allergan Evaluation of Abicipar Pegol (AGN-150998) in Patients with Decreased Vision Due to Diabetic Macular Edema
Allergan A Multicenter, Open-label, Randomized Study Comparing the Efficacy and Safety of 700 µg Dexamethasone Posterior Segment Drug Delivery System (DEX PS DDS) to Ranibizumab in Patients with Diabetic Macular Edema
Ampio
(Optina)
A Randomized, Placebo-Controlled, Parallel, Double-Masked Study to Evaluate the Efficacy and Safety of Two Doses of Oral Optina™ in Adult Patients with Diabetic Macular Edema
Genentech A Study of Ranibizumab Administered Monthly or on an As-Needed Basis in Patients with Subfoveal Neovascular Age-Related Macular Degeneration (HARBOR)
Genentech A Study Evaluating Dosing Regimens for Treatment with Intravitreal Ranibizumab Injections in Subjects with Macular Edema Following Retinal Vein Occlusion (SHORE)
Novartis A multicenter, randomized, sham-control, proof-of-concept study of intravitreal LFG316 in patients with geographic atrophy associated with age-related macular degeneration
PanOptica A Phase 1 Open-Label, Multi-Center Trial with Randomization to Dose to Evaluate the Safety and Tolerability of Topical Ocular PAN-90806 in Patients with Neovascular Age-Related Macular Degeneration (AMD)
Regeneron
REVIEW
Rigorous Evaluation of Vision and safety with Intravitreal Afilibercept injection dosed Every 8 weeks over 2 years in neovascular AMD
Regeneron Study of Intravitreal Administration of VEGF Trap-Eye in Patients with Diabetic Macular Edema (VISTA DME)
Regeneron Study to Assess the Clinical Efficacy and Safety of VEGF Trap-Eye (Intravitreal Aflibercept Injection [IAI]), Also Commercially Known as EYLEA™ in Patients with Branch Retinal Vein Occlusion (BRVO)
Santen Study Assessing Double-masked Uveitis Treatment (SAKURA): The purpose of this study is to evaluate the safety and efficacy of intravitreal injections of DE-109 ophthalmic suspension